Ferric citrate spans mineral metabolism and anemia domains in ESRD: a review of efficacy and safety data

Dose-Response and Efficacy of Ferric Citrate to Treat Hyperphosphatemia in Hemodialysis Patients: A Short-term Randomized Trial

(2013) Jamie P. Dwyer et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Rationale and study design of a three-period, 58-week trial of ferric citrate as a phosphate binder in patients with ESRD on dialysis

(2012) Kausik Umanath et al.   Hemodialysis International

The Safety and Tolerability of Ferric Citrate as a Phosphate Binder in Dialysis Patients

(2012) Marvin Sinsakul et al.   NEPHRON CLINICAL PRACTICE

Iron Overload in Human Disease

(2012) Robert E. Fleming et al.   NEW ENGLAND JOURNAL OF MEDICINE

Economic Evaluation of Sevelamer versus Calcium-Based Phosphate Binders in Hemodialysis Patients: A Secondary Analysis using Centers for Medicare & Medicaid Services Data

(2009) W. L. St. Peter et al.   Clinical Journal of the American Society of Nephrology

Oral phosphate binders

(2009) Alastair J. Hutchison   KIDNEY INTERNATIONAL